Is drug treatment superior to allografting as first-line therapy in chronic myeloid leukemia?

被引：0
|
作者：
Hughes, Timothy [1 ]
机构：
[1] Inst Med & Vet Sci, Div Hematol, Adelaide, SA 5000, Australia
来源：
NATURE CLINICAL PRACTICE ONCOLOGY | 2008年 / 5卷 / 01期
关键词：
allogeneic transplantation; chronic myeloid leukemia; drug treatment;
D O I：
10.1038/ncponc0983
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：14 / 15
页数：2
相关论文
共 50 条
  • [31] First-line therapy of advanced chronic lymphocytic leukemia
    Wilhelm, M
    Tony, HP
    RueckleLanz, H
    Wilms, K
    LEUKEMIA, 1997, 11 : S14 - S18
  • [32] Choosing first-line therapy for chronic lymphocytic leukemia
    Jaglowski, Samantha
    Jones, Jeffrey A.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (09) : 1379 - 1390
  • [33] Early cytogenetic and molecular response during first-line treatment of chronic myeloid leukemia in chronic phase
    Quintas-Cardama, Alfonso
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    CANCER, 2011, 117 (23) : 5261 - 5270
  • [34] The choice of first-line Chronic Myelogenous Leukemia treatment
    Fava, Carmen
    Rege-Cambrin, Giovanna
    Saglio, Giuseppe
    ANNALS OF HEMATOLOGY, 2015, 94 : S123 - S131
  • [35] The choice of first-line Chronic Myelogenous Leukemia treatment
    Carmen Fava
    Giovanna Rege-Cambrin
    Giuseppe Saglio
    Annals of Hematology, 2015, 94 : 123 - 131
  • [36] Cost-effectiveness of imatinib (GLEEVEC) as first-line treatment in chronic myeloid leukemia (CML)
    El Quagari, K
    Talbot, W
    Baladi, JF
    VALUE IN HEALTH, 2004, 7 (06) : 669 - 669
  • [37] Low-Dose Dasatinib As First-Line Treatment for Chronic Myeloid Leukemia: Preliminary Report
    Santana-Hernandez, Paola
    Pedraza, Perla Rocio Colunga
    Duque, Guillermo Sotomayor
    Gomez-De Leon, Andres
    Tarin Arzaga, Luz del Carmen
    Aguirre, Cesar Homero Gutierrez
    Rodriguez, Olga Cantu
    Gomez-Almaguer, David
    BLOOD, 2017, 130
  • [38] Hypomethylating agents as first-line therapy in acute myeloid leukemia (AML).
    Bailey, Samuel D.
    Gul, Zartash
    Slone, Stacey A.
    Van Meter, Emily Marie
    Lawson, Amber
    Raufi, Ali
    Hayslip, John W.
    Monohan, Gregory
    Howard, Dianna S.
    McDonagh, Kevin T.
    Alkadhimi, Zaid
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [39] Assessment of quality of life with imatinib mesylate as first-line treatment in chronic phase-chronic myeloid leukemia
    Aziz, Zeba
    Iqbal, Javaid
    Aaqib, Muhammad
    Akram, Muhammad
    Saeed, Asif
    LEUKEMIA & LYMPHOMA, 2011, 52 (06) : 1017 - 1023
  • [40] FIRST-LINE THERAPY AND SEQUENTIAL APPLICATION OF TYROSINE KINASE INHIBITORS FOR CHRONIC MYELOID LEUKEMIA TREATMENT-A CLINICAL DECISION ANALYSIS
    Rochau, U.
    Sroczynski, G.
    Wolf, D.
    Schmidt, S.
    Conrads-Frank, A.
    Jahn, B.
    Saverno, K.
    Brixner, D.
    Gastl, G.
    Radich, J.
    Siebert, U.
    HAEMATOLOGICA, 2013, 98 : 304 - 305
12345